Cargando…

Cardiac biomarkers in pediatric CKD—a prospective follow-up study

BACKGROUND: The N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitive cardiac-specific troponin T (hs-cTnT) are associated with abnormal cardiac structure and function and an increased risk of cardiovascular death in chronic kidney disease (CKD) patients. There is limited knowledg...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindblad, Ylva Tranæus, Vavilis, Georgios, Chromek, Milan, Quershi, Abdul Rashid, Löwbeer, Christian, Bárány, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587089/
https://www.ncbi.nlm.nih.gov/pubmed/35294668
http://dx.doi.org/10.1007/s00467-022-05481-w
_version_ 1784813833464840192
author Lindblad, Ylva Tranæus
Vavilis, Georgios
Chromek, Milan
Quershi, Abdul Rashid
Löwbeer, Christian
Bárány, Peter
author_facet Lindblad, Ylva Tranæus
Vavilis, Georgios
Chromek, Milan
Quershi, Abdul Rashid
Löwbeer, Christian
Bárány, Peter
author_sort Lindblad, Ylva Tranæus
collection PubMed
description BACKGROUND: The N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitive cardiac-specific troponin T (hs-cTnT) are associated with abnormal cardiac structure and function and an increased risk of cardiovascular death in chronic kidney disease (CKD) patients. There is limited knowledge about these cardiac markers in pediatric CKD patients. METHODS: Longitudinal levels of NT-proBNP and hs-cTnT were analyzed in 48 pediatric patients, 22 with CKD (GFR range 8.8–68 mL/min/1.73 m(2)) and 26 transplanted patients (CKD-T; GFR range 30–99 mL/min/1.73 m(2)). Follow-up was scheduled after 1 and 3 years. Longitudinal patterns and associations to kidney function, cardiovascular risk markers, and echocardiographic parameters were assessed. RESULTS: High NT-proBNP was present in 27% of CKD and 11% of CKD-T patients. Similarly 32% of CKD and 8% of CKD-T patients had elevated hs-cTnT levels. In longitudinal multivariate analyses, high log NT-proBNP was associated with low GFR (β =  − 0.01, p = 0.01) and elevated left ventricular mass index (LVMI; β = 0.02, p = 0.05). The strong association to LVMI remained when using GFR-adjusted NT-proBNP in similar analysis. Patients with left ventricular hypertrophy (LVH) also had higher NT-proBNP (235 [146–301] ng/L) than patients without LVH (86 [11–477] ng/L), p = 0.02. High hs-cTnT over-time was also associated with low GFR (β =  − 0.007, p = 0.01) and a low cc-TDI e´/a´, indicating a worse LV diastolic function (β =  − 0.09, p = 0.05). This association did not persist for GFR-adjusted hs-cTnT. CONCLUSIONS: NT-proBNP and hs-cTnT are elevated in pediatric CKD and CKD-T patients. GFR-adjusted NT-proBNP was associated with longitudinal levels of elevated LVMI suggesting this might be a marker for early subclinical myocardial damage. GRAPHICAL ABSTRACT: A higher resolution version of the Graphical abstract is available as Supplementary information. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains a graphical abstract available at 10.1007/s00467-022-05481-w.
format Online
Article
Text
id pubmed-9587089
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-95870892022-10-23 Cardiac biomarkers in pediatric CKD—a prospective follow-up study Lindblad, Ylva Tranæus Vavilis, Georgios Chromek, Milan Quershi, Abdul Rashid Löwbeer, Christian Bárány, Peter Pediatr Nephrol Original Article BACKGROUND: The N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitive cardiac-specific troponin T (hs-cTnT) are associated with abnormal cardiac structure and function and an increased risk of cardiovascular death in chronic kidney disease (CKD) patients. There is limited knowledge about these cardiac markers in pediatric CKD patients. METHODS: Longitudinal levels of NT-proBNP and hs-cTnT were analyzed in 48 pediatric patients, 22 with CKD (GFR range 8.8–68 mL/min/1.73 m(2)) and 26 transplanted patients (CKD-T; GFR range 30–99 mL/min/1.73 m(2)). Follow-up was scheduled after 1 and 3 years. Longitudinal patterns and associations to kidney function, cardiovascular risk markers, and echocardiographic parameters were assessed. RESULTS: High NT-proBNP was present in 27% of CKD and 11% of CKD-T patients. Similarly 32% of CKD and 8% of CKD-T patients had elevated hs-cTnT levels. In longitudinal multivariate analyses, high log NT-proBNP was associated with low GFR (β =  − 0.01, p = 0.01) and elevated left ventricular mass index (LVMI; β = 0.02, p = 0.05). The strong association to LVMI remained when using GFR-adjusted NT-proBNP in similar analysis. Patients with left ventricular hypertrophy (LVH) also had higher NT-proBNP (235 [146–301] ng/L) than patients without LVH (86 [11–477] ng/L), p = 0.02. High hs-cTnT over-time was also associated with low GFR (β =  − 0.007, p = 0.01) and a low cc-TDI e´/a´, indicating a worse LV diastolic function (β =  − 0.09, p = 0.05). This association did not persist for GFR-adjusted hs-cTnT. CONCLUSIONS: NT-proBNP and hs-cTnT are elevated in pediatric CKD and CKD-T patients. GFR-adjusted NT-proBNP was associated with longitudinal levels of elevated LVMI suggesting this might be a marker for early subclinical myocardial damage. GRAPHICAL ABSTRACT: A higher resolution version of the Graphical abstract is available as Supplementary information. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains a graphical abstract available at 10.1007/s00467-022-05481-w. Springer Berlin Heidelberg 2022-03-16 2022 /pmc/articles/PMC9587089/ /pubmed/35294668 http://dx.doi.org/10.1007/s00467-022-05481-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Lindblad, Ylva Tranæus
Vavilis, Georgios
Chromek, Milan
Quershi, Abdul Rashid
Löwbeer, Christian
Bárány, Peter
Cardiac biomarkers in pediatric CKD—a prospective follow-up study
title Cardiac biomarkers in pediatric CKD—a prospective follow-up study
title_full Cardiac biomarkers in pediatric CKD—a prospective follow-up study
title_fullStr Cardiac biomarkers in pediatric CKD—a prospective follow-up study
title_full_unstemmed Cardiac biomarkers in pediatric CKD—a prospective follow-up study
title_short Cardiac biomarkers in pediatric CKD—a prospective follow-up study
title_sort cardiac biomarkers in pediatric ckd—a prospective follow-up study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587089/
https://www.ncbi.nlm.nih.gov/pubmed/35294668
http://dx.doi.org/10.1007/s00467-022-05481-w
work_keys_str_mv AT lindbladylvatranæus cardiacbiomarkersinpediatricckdaprospectivefollowupstudy
AT vavilisgeorgios cardiacbiomarkersinpediatricckdaprospectivefollowupstudy
AT chromekmilan cardiacbiomarkersinpediatricckdaprospectivefollowupstudy
AT quershiabdulrashid cardiacbiomarkersinpediatricckdaprospectivefollowupstudy
AT lowbeerchristian cardiacbiomarkersinpediatricckdaprospectivefollowupstudy
AT baranypeter cardiacbiomarkersinpediatricckdaprospectivefollowupstudy